Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
For additional glycemic control, empagliflozin may be increased to a maximum total daily dosage of 25 mg in patients tolerating 10 mg daily and metformin HCl may be increased to a maximum total daily dosage of 2,000 mg, with gradual escalation to reduce gastrointestinal adverse reactions with metformin HCl [see Adverse Reactions (6.1)]
Compounded versus brand-name outcomes An important consideration that dosage charts alone do not capture is consistency of the active ingredient
Researchers should use PrymaLabs Peptide Calculator for precise cjc ipa dose calculations
Simon A, Monier F, Emonard H, et al
Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]
